The presence [number (percentage)] of individual MMPs and TIMPs in different stages of gastric cancer
| Tumour stage | ||||||
|---|---|---|---|---|---|---|
| 1a (n=5) | 1b (n=17) | 2 (n=43) | 3a (n=8) | 4 (n=1) | Total | |
| MMP-1 | ||||||
| Strong | 1 (20) | 8 (47) | 17 (40) | 1 (13) | 1(100) | 28 (38) |
| Weak | 1 (20) | 5 (29) | 16 (37) | 4 (50) | 0 | 26 (35) |
| Absent | 3 (60) | 4 (24) | 10 (23) | 3 (37) | 0 | 20 (27) |
| Total | 5 (100) | 17 (100) | 43 (100) | 8 (100) | 1 (100) | 74 (100) |
| MMP-2 | ||||||
| Strong | 3 (60) | 13 (76) | 39 (90) | 7 (87) | 1 (100) | 63 (86) |
| Weak | 1 (20) | 3 (18) | 2 (5) | 1 (13) | 0 | 7 (9) |
| Absent | 1 (20) | 1 (6) | 2 (5) | 0 | 0 | 4 (5) |
| Total | 5 (100) | 17 (100) | 43 (100) | 8 (100) | 1 (100) | 74 (100) |
| MMP-3 | ||||||
| Strong | 0 | 0 | 3 (7) | 0 | 0 | 3 (4) |
| Weak | 0 | 4 (24) | 9 (21) | 4 (50) | 0 | 17 (23) |
| Absent | 5 (100) | 13 (76) | 31 (72) | 4 (50) | 1 (100) | 54 (73) |
| Total | 5 (100) | 17 (100) | 43 (100) | 8 (100) | 1 (100) | 74 (100) |
| MMP-9 | ||||||
| Strong | 2 (40) | 7 (41) | 19 (44) | 2 (25) | 0 | 30 (41) |
| Weak | 2 (40) | 7 (41) | 15 (35) | 3 (37.5) | 1 (100) | 28 (38) |
| Absent | 1 (20) | 3 (18) | 9 (21) | 3 (37.5) | 0 | 16 (21) |
| Total | 5 (100) | 17 (100) | 43 (100) | 8 (100) | 1 (100) | 74 (100) |
| TIMP-1 | ||||||
| Strong | 1 (20) | 2 (12) | 7 (16) | 0 | 0 | 10 (14) |
| Weak | 2 (40) | 6 (35) | 12 (28) | 0 | 0 | 20 (27) |
| Absent | 2 (40) | 9 (53) | 24 (56) | 8 (100) | 1 (100) | 44 (59) |
| Total | 5 (100) | 17 (100) | 43 (100) | 8 (100) | 1 (100) | 74 (100) |
| TIMP-2 | ||||||
| Strong | 1 (20) | 1 (6) | 10 (23) | 0 | 0 | 12 (16) |
| Weak | 1 (20) | 7 (41) | 16 (37) | 5 (62.5) | 1 (100) | 30 (41) |
| Absent | 3 (60) | 9 (53) | 17 (40) | 3 (37.5) | 0 | 32 (43) |
| Total | 5 (100) | 17 (100) | 43 (100) | 8 (100) | 1 (100) | 74 (100) |
Results are expressed as number (%).